Skip to main content

Advertisement

SpringerLink
Log in

New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy

A prospective study of efficacy, safety and tolerability

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, Miller RG, Griffin JW (1993) Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 33:237–242

    Article  PubMed  CAS  Google Scholar 

  2. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE (2000) Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 55:1256–1262

    PubMed  CAS  Google Scholar 

  3. Kallenberg CG (2007) A 10 % ready-touse intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency. Clin Exp Immunol 150:437–441

    PubMed  CAS  Google Scholar 

  4. Medical Research Council (1979) Aids to the Examination of the Peripheral Nervous System. London, England: HMSO, pp 1–2

  5. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA (2002) Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 72:596–601

    Article  PubMed  CAS  Google Scholar 

  6. Van Asseldonk JT, Franssen H, Van den Berg-Vos RM, Wokke JH, Van den Berg LH (2005) Multifocal motor neuropathy. Lancet Neurol 4:309–319

    Article  PubMed  Google Scholar 

  7. Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, Jennekens FG, Wokke JH (1995) Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59:248–252

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Neurology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands

    E. A. Cats, W.-L. van der Pol, S. Piepers, N. C. Notermans & L. H. van den Berg

  2. Dept. of Neurology, St. Lucas Andreas Hospital, Amsterdam, The Netherlands

    R. M. van den Berg-Vos

Authors
  1. E. A. Cats
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W.-L. van der Pol
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Piepers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. C. Notermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. M. van den Berg-Vos
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. H. van den Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. A. Cats.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cats, E.A., van der Pol, WL., Piepers, S. et al. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy. J Neurol 255, 1598–1599 (2008). https://doi.org/10.1007/s00415-008-0979-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0979-3

Keywords

Search

Navigation